Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study.,Diabetes, Obesity and Metabolism

当前位置： X-MOL 学术 › Diabetes Obes. Metab. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study.
Diabetes, Obesity and Metabolism ( IF 5.8 ) Pub Date : 2020-04-03 , DOI: 10.1111/dom.14046
Jacob Y Cao _{1,

2} , Boris Waldman _{1,

2} , Rachel O'Connell ₁ , David R Sullivan _{1,

2} , Russell S Scott ₃ , Nanda Aryal ₁ , Val Gebski ₁ , Ian Marschner ₁ , Marja-Riitta Taskinen ₄ , John R Simes _{1,

2} , Neil McGill _{1,

2} , Alicia J Jenkins _{1,

2} , Anthony C Keech _{1,

2} ,

Affiliation

To explore the relationship between baseline uric acid (UA) levels and long‐term cardiovascular events in adults with type 2 diabetes (T2D) and to determine whether the cardioprotective effects of fenofibrate are partly mediated through its UA‐lowering effects.

中文翻译：